Attention-deficit/hyperactivity disorder: Identifying high priority future research needs

Journal of Psychiatric Practice

Volumn 20, Issue 2, 2014, Pages 104-117

  Gaynes, Bradley N ^a   Christian, Robert ^a   Saavedra, Lissette M ^b   Wines, Roberta ^a   Jonas, Daniel E ^a   Viswanathan, Meera ^b   Ellis, Alan R ^a   Woodell, Carol ^b   Carey, Timothy S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

attention deficit hyperactivity disorder (ADHD); effectiveness; future research needs; psychopharmacology; psychosocial interventions; treatment

Indexed keywords

ATOMOXETINE; GUANFACINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD PARENT RELATION; COMPARATIVE EFFECTIVENESS; CONDUCT DISORDER; DAY CARE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISRUPTIVE BEHAVIOR; DRUG SAFETY; EVIDENCE BASED MEDICINE; FAMILY; FUNDING; GROUPS BY AGE; HEALTH CARE PERSONNEL; HUMAN; LONG TERM CARE; MEDICAL RESEARCH; OPPOSITIONAL DEFIANT DISORDER; OUTCOME ASSESSMENT; PARENTAL BEHAVIOR; PARENTING EDUCATION; PRACTICE GUIDELINE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; SCHOOL HEALTH SERVICE; STUDY DESIGN; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; GOVERNMENT; HEALTH SERVICES RESEARCH; LITERATURE; METHODOLOGY; STANDARDS; UNITED STATES;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOMEDICAL RESEARCH; HEALTH SERVICES RESEARCH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 84896924619     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000445245.46424.25     Document Type: Article

References (26)

1. Pliszka S, AACP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Can Acad Child Adolesc Psychiatry 2007;46: 894-921.
2. Greenhill LL, Posner K, Vaughan BS, et al. Attention deficit hyperactivity disorder in preschool children. Child Adolesc Psychiatr Clin North Am 2008;17:347-66, ix.
3. Simon V, Czobor P, Balint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. Br J Psychiatry 2009;194:204-11.
4. Charach A, Dashti B, Carson P, et al. Attention deficit hyperactivity disorder: Effectiveness of treatment in atrisk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. Rockville, MD: Agency for Healthcare Research and Quality Comparative Effectiveness Review No. 44; 2011 (available at www.effectivehealthcare.ahrq. gov/search-forguides- reviews-and-reports/?pageaction=displayproduct& productID=818, accessed February 3, 2014).
5. Greenhill L, Kollins S, Abikoff H, et al. Efficacy and safety of immediate-release methyl phenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45:1284-93.
6. Sallee FR, Lyne A, Wigal T, et al. Longterm safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009;19:215-26.
7. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168-79.
8. Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001;40: 159-67.
9. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study:Comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40: 147-58.
10. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attentiondeficit/ hyperactivity disorder. Pediatrics 2004;113:754-61.
11. Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 2007;46:989-1002.
12. Molina BS, Hinshaw SP, Swanson JM, et al., The MTA at 8 years: prospective follow-up of children treated for combined- type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009;48:484-500.
13. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762-9.
14. Froehlich TE, Lanphear BP, Epstein JN, et al. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007;161:857-64.
15. Bokhari F, Mayes R, Scheffler RM. An analysis of the significant variation in psychostimulant use across the U.S. Pharmacoepidemiol Drug Saf 2005;14:267-75.
16. Fulton BD, Scheffler RM, Hinshaw SP, et al. National variation of ADHD diagnostic prevalence and medication use: Health care providers and education policies. Psychiatr Serv 2009;60:1075-83.
17. Eyestone LL, Howell RJ. An epidemiological study of attention-deficit hyperactivity disorder and major depression in a male prison population. Bull Am Acad Psychiatry Law 1994;22:181-93.
18. Centers for Disease Control and Prevention. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Morb Mortal Wkly Rep 2005;54:842-7.
19. Report of the International Narcotics Control Board for 2009. Psychotropic Substances-Technical Report, 2009 (available at www.incb.org/documents/Psychotropics/technical- publications/2009/Psychotropic- Report-2009.pdf, accessed February 24, 2014)
20. Owens DK, Lohr KN, Atkins D, et al. AHRQ series paper 5: Grading the strength of a body of evidence when comparing medical interventions-Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol 2010; 63: 513-23.
21. Gaynes B, Christian R, Saavedra L, et al. Future research needs for attention deficit hyperactivity disorder: Effectiveness of treatment in at-risk preschoolers, longterm effectiveness in all ages, and variability in prevalence, diagnosis, and treatment. Future research needs No. 9 (prepared by RTI-UNC Evidence-based Practice Center under Contract No. 290-2007-10056-I) Rockville, MD: Agency for Healthcare Research and Quality; 2012. AHRQ Publication No. 12-EHC008-EF (available at www.ncbi.nlm.nih.gov/books/NBK83972, accessed Febru - ary 3, 2014).
22. Agency for Healthcare Research and Quality Effective Health Care Program. How are research topics chosen? (available at www.effectivehealthcare.ahrq.gov/ index.cfm/submit-a-suggestion-for-research/how-are-researchtopics- chosen, accessed February 3, 2014).
23. Whitlock EP, Lopez SA, Chang S, et al. AHRQ series paper 3: Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program. J Clin Epidemiol 2010; 63: 491-501.
24. Carey TS, Sanders GD, Viswanathan M, et al. Framework for considering study designs for future research needs. Methods future research needs paper no. 8 [Internet]. Rockville, MD: Agency for Healthcare Research and Quality 2012 (prepared by the RTI-UNC Evidence-based Practice Center under Contract No. 290-2007-10056-I) (available at www.ncbi.nlm.nih.gov/books/NBK95273, accessed February 3, 2014).
25. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attentiondeficit/ hyperactivity disorder in children and adolescents. Pediatrics 2011;128;1007; originally published online October 16, 2011; DOI: 10.1542/peds.2011-2654. The online version of this article, along with updated information and services, is available at http://pediatrics.aappublications. org/content/128/5/1007.full. html, accessed March 3, 2014.
26. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attentiondeficit/ hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-86.